Posts Tagged ‘Monsanto’

Study Finds Genetically Modified Corn Causing Organ Damage To Rats

Study Finds Genetically Modified Corn Causing Organ Damage To Rats

corn - tbiCourtesy of Vincent Fernando at Clusterstock/The Business Insider

A new study concludes that some varieties of genetically modified corn may cause organ damage.

Regardless of which specific varieties of genemtic modification might be dangerous, if serious health risks were proven for any genetically modified type of food, it could hit all types since the level of regulatory scrutiny would likely increase ten-fold.

It would most certainly be bad news for Monsanto (MON).

Journal of Biological Sciences: We therefore conclude that our data strongly suggests that these GM maize varieties induce a state of hepatorenal toxicity. This can be due to the new pesticides (herbicide or insecticide) present specifically in each type of GM maize, although unintended metabolic effects due to the mutagenic properties of the GM transformation process cannot be excluded [42]. All three GM maize varieties contain a distinctly different pesticide residue associated with their particular GM event (glyphosate and AMPA in NK 603, modified Cry1Ab in MON 810, modified Cry3Bb1 in MON 863). These substances have never before been an integral part of the human or animal diet and therefore their health consequences for those who consume them, especially over long time periods are currently unknown….

In conclusion, our data presented here strongly recommend that additional long-term (up to 2 years) animal feeding studies be performed in at least three species, preferably also multi-generational, to provide true scientifically valid data on the acute and chronic toxic effects of GM crops, feed and foods.

Read more here >

We’d be curious to see how this pans out, it seems to be far from a done deal given that they recommend doing further study in order to achieve ‘true scientifically valid data’. It also seems that the problem may have had more to do with the pesticides involved rather than the actual act of modifying genes.

As always, one needs to balance the benefits vs. the cost of any technology. We’re reminded of how food preservatives came under fire as unhealthy additives, without regard to the fact that large amounts of people used to die on a regular basis from food poisoning before their broad usage. Still, if the danger is real, it should obviously be investigated. Hopefully, for the sake of agricultural productivity, there aren’t any major health risks.

(Via Naked Capitalism)

 


Tags: , , , , , , , ,




Is Monsanto Worth a Look? Depends on Which Monsanto You’re Talking About.

Is Monsanto Worth a Look? Depends on Which Monsanto You’re Talking About.

Disclaimer:  This is not research, advice or an invitation to trade or invest.  My comments below are simply some observations based on publicly available information.  Do not trade based on anything you read here.

Monsanto (MON) is becoming quite the controversial stock in light of the dichotomy of near-term and long-term outlooks.  You could make the case that this is true for all of the agriculture stocks (brutal farm incomes and spending this year but multi-year Ag Supercycle on the horizon). 

Roundup - the trouble with Monsanto

Let’s look at MON as a microcosm for the ag story at large…

Monsanto’s long-term story is one of the most exciting and imagination-capturing I can think of.

The short version goes something like this: 

The planet’s population is not only growing, it is becoming more prosperous.  As a result, the emerging middle class (China, Latin America, India, Africa) will be looking to upgrade the food they consume and to include more proteins in their diet.  In order to meet this new protein demand, roughly four times the amount of productivity will be required of the available global farmland.  The best way to accomplish this is with enhanced seed and genomic technology, which puts the industry leader, Monsanto, squarely in the driver’s seat for this global mega-trend.

OK, this is all well and good, but right now in 2009, the $43 billion dollar company is not quite being driven by the Ag-Tech story, it is instead being driven in part by the results of its weed-killer business, also known as Roundup.

Monsanto put out an earnings forecast this week and had to lower its 2009 and 2010 profit estimates in light of the fact that consumers are skipping the brand-name Roundup product in favor of cheaper generic herbicides.

roundup on monsantoThe company is pegging its 2010 earnings at $3.10 to $3.30 a share, The Street was thinking more like $4.30.  Not pretty.

Monsanto’s CEO is telling us that the Roundup business will only be 15% of the profit mix at Monsanto by 2012 as the seed and genomic businesses kick into high gear and go to 85% of profits.  The question becomes whether or not you are willing to see through the valley into the intermediate term when this prospect has the potential to become reality. 

The analysts I’ve…
continue reading


Tags: , , , ,




 
 
 

Phil's Favorites

Catching Up On My Investment Mistakes From The March Panic

 

Catching Up On My Investment Mistakes From The March Panic Courtesy of Howard Lindzon

It is fun to talk about winners.

It has been relatively easy to win over the years as I am an optimist and able to live a life in the sun, on the beach and in the software industry.

So, how is it possible to still be so wrong all the time, most recently during the crash in March of this year?

One reason is, to give myself a bit of a break, investing is hard.

I was well prepared going into the crash/panic, and was writing and podcasting to keep me on a plan ‘not to panic’ and to buy certain stocks at certain levels. I did all that. It ...



more from Ilene

Zero Hedge

Operation Warp Speed Awards Novavax $1.6 Billion For COVID Vaccine 

Courtesy of ZeroHedge View original post here.

With US equity futures under pressure on Tuesday morning - it's not surprising whatsoever that hopium-inspiring vaccine headlines are hitting the tape. 

Novavax was awarded $1.6 Billion in funding via Operation Warp Speed to support "large-scale manufacturing of NVX-COV2373."

  • NOVAVAX ANNOUNCES $1.6 BILLION FUNDING FROM OPERATION WARP SPEED

...

more from Tyler

The Technical Traders

Big Funds to Pull Money OUT of Stocks: 2nd Wave to Hit Economy

Courtesy of Technical Traders

TOPICS IN THIS INTERVIEW:

-Big funds to pull money out of markets.

-Falling dollar to really start to benefit gold

-Gold miners showing signs of life.

-$2,000 gold will change people’s mindsets in gold.

-Gold or silver-backed currency will send metals through the roof.

Get Chris Vermeulen’s Trades – Click Here

...

more from Tech. Traders

ValueWalk

New Climate Risk Rating Of Companies For Investors

By Jacob Wolinsky. Originally published at ValueWalk.

  • New dataset gives investors temperature ratings for 4,000 global companies, based on targets to cut all GHG emissions they are responsible for.
  • Based on a new approach currently being developed by CDP and WWF, CDP temperature ratings can be used for gauging the temperature pathway of investor portfolios, funds and stock indices.
  • Europe’s largest asset manager Amundi first to use the rating as part of its ESG analysis, and for the monitoring of four global multisector equity funds[1].

Q1 2020 hedge fund letters, conferences and more

CD...

more from ValueWalk

Kimble Charting Solutions

Shangai Index Soars Higher, Testing 11-Year Breakout Level!

Courtesy of Chris Kimble

Is the Shanghai Index (SSE) about to experience a long-term breakout and send the world a bullish message?

An 11-year breakout test is in play that will answer this question.

The Shanghai index trend continues to send a bullish message, as it has created a series of higher lows for the past 24-years above line (1).

This long-term support line was tested at the March lows at (2) and it held.

The rally off the lows has the index testing dual resistance at (3).

Will this important index succeed in breaking out? If it does at (3), it will send a very bu...



more from Kimble C.S.

Biotech/COVID-19

As U.S. buys up remdesivir, 'vaccine nationalism' threatens access to COVID-19 treatments

 

As U.S. buys up remdesivir, ‘vaccine nationalism’ threatens access to COVID-19 treatments

Are we really all in this together? ‘Vaccine nationalism’ must be addressed to ensure equitable distribution of a COVID-19 vaccine. (Pixabay)

Courtesy of Joel Lexchin, University of Toronto

At the end of June, the United States government announced that it had ...



more from Biotech/COVID-19

Chart School

Golds quick price move increases the odds of a correction

Courtesy of Read the Ticker

Every market corrects, maybe profit taking, maybe of allowing those who missed out, to get in!


The current open interest on the gold contract looks to high after a very fast price move, it looks like 2008 may be repeating. A quick flushing out of the weak hands open interest may take place before a real advance in price takes place. The correction may be on the back of a wider sell off of risk assets (either before of after US elections) as all assets suffer contagion selling (just like 2008).

This blog view is a gold price correction of 10% to 20% range is a buying opportunity. Of course we may see  a very minor price correction but a long time correction, a price or time is correction is expected, we shall watch and...

more from Chart School

Lee's Free Thinking

These Charts Show COVID 19 Is Spreading in the US and Will Kill the Economy

 

These Charts Show COVID 19 Is Spreading in the US and Will Kill the Economy

Courtesy of  

The COVID 19 pandemic is, predictably, worsening again in much of the US. Only the Northeast, and to a lesser extent some Midwestern states, have been consistently improving. And that trend could also reverse as those states fully reopen.

The problem in the US seems to be widespread public resistance to recommended practices of social distancing and mask wearing. In countries where these practices have been practi...



more from Lee

Digital Currencies

Blockchains can trace foods from farm to plate, but the industry is still behind the curve

 

Blockchains can trace foods from farm to plate, but the industry is still behind the curve

App-etising? LDprod

Courtesy of Michael Rogerson, University of Bath and Glenn Parry, University of Surrey

Food supply chains were vulnerable long before the coronavirus pandemic. Recent scandals have ranged from modern slavery ...



more from Bitcoin

Members' Corner

Coronavirus, 'Plandemic' and the seven traits of conspiratorial thinking

 

Coronavirus, 'Plandemic' and the seven traits of conspiratorial thinking

No matter the details of the plot, conspiracy theories follow common patterns of thought. Ranta Images/iStock/Getty Images Plus

Courtesy of John Cook, George Mason University; Sander van der Linden, University of Cambridge; Stephan Lewandowsky...



more from Our Members

Insider Scoop

Economic Data Scheduled For Friday

Courtesy of Benzinga

  • Data on nonfarm payrolls and unemployment rate for March will be released at 8:30 a.m. ET.
  • US Services Purchasing Managers' Index for March is scheduled for release at 9:45 a.m. ET.
  • The ISM's non-manufacturing index for March will be released at 10:00 a.m. ET.
  • The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
...

http://www.insidercow.com/ more from Insider

Promotions

Free, Live Webinar on Stocks, Options and Trading Strategies

TODAY's LIVE webinar on stocks, options and trading strategy is open to all!

Feb. 26, 1pm EST

Click HERE to join the PSW weekly webinar at 1 pm EST.

Phil will discuss positions, COVID-19, market volatility -- the selloff -- and more! 

This week, we also have a special presentation from Mike Anton of TradeExchange.com. It's a new service that we're excited to be a part of! 

Mike will show off the TradeExchange's new platform which you can try for free.  

...

more from Promotions

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. Contact Ilene to learn about our affiliate and content sharing programs.